Works matching IS 00099236 AND DT 2012 AND VI 92 AND IP 5

Results: 28

The UCSF-FDA TransPortal: A Public Drug Transporter Database.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 545, doi. 10.1038/clpt.2012.44
By:
- Morrissey, K M;
- Wen, C C;
- Johns, S J;
- Zhang, L;
- Huang, S-M;
- Giacomini, K M
Publication type:
Article
High-Dose Ibuprofen Therapy for Patent Ductus Arteriosus in Extremely Preterm Neonates: Do We Have a Final Answer?
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 557, doi. 10.1038/clpt.2012.150
By:
- Sajan Saini, S;
- Mahajan, V
Publication type:
Article
Fruit Juices as Perpetrators of Drug Interactions: The Role of Organic Anion-Transporting Polypeptides.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 622, doi. 10.1038/clpt.2012.159
By:
- Dolton, M J;
- Roufogalis, B D;
- McLachlan, A J
Publication type:
Article
A Clinician-Driven Automated System for Integration of Pharmacogenetic Interpretations Into an Electronic Medical Record.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 563, doi. 10.1038/clpt.2012.140
By:
- Hicks, J K;
- Crews, K R;
- Hoffman, J M;
- Kornegay, N M;
- Wilkinson, M R;
- Lorier, R;
- Stoddard, A;
- Yang, W;
- Smith, C;
- Fernandez, C A;
- Cross, S J;
- Haidar, C;
- Baker, D K;
- Howard, S C;
- Evans, W E;
- Broeckel, U;
- Relling, M V
Publication type:
Article
Understanding the Critical Disposition Pathways of Statins to Assess Drug-Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 584, doi. 10.1038/clpt.2012.163
By:
- Elsby, R;
- Hilgendorf, C;
- Fenner, K
Publication type:
Article
Zebrafish as a Model to Study Drug Transporters at the Blood-Brain Barrier.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 567, doi. 10.1038/clpt.2012.168
By:
- Umans, R A;
- Taylor, M R
Publication type:
Article
Simulations Using a Drug-Disease Modeling Framework and Phase II Data Predict Phase III Survival Outcome in First-Line Non-Small-Cell Lung Cancer.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 631, doi. 10.1038/clpt.2012.78
By:
- Claret, L;
- Lu, J-F;
- Bruno, R;
- Hsu, C-P;
- Hei, Y-J;
- Sun, Y-N
Publication type:
Article
Response to 'High-Dose Ibuprofen Therapy for Patent Ductus Arteriosus in Extremely Preterm Neonates: Do We Have a Final Answer?'.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 558, doi. 10.1038/clpt.2012.162
By:
- Dani, C
Publication type:
Article
Models of Excellence: Improving Oncology Drug Development.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 548, doi. 10.1038/clpt.2012.99
By:
- Sharma, M R;
- Maitland, M L;
- Ratain, M J
Publication type:
Article
Advancing Pharmacometrics and Systems Pharmacology.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 535, doi. 10.1038/clpt.2012.151
By:
- Waldman, S A;
- Terzic, A
Publication type:
Article
Use of Healthy Volunteers Drives Clinical Oncology Drug Development Decision Making.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 571, doi. 10.1038/clpt.2012.157
By:
- Iwamoto, M;
- Iannone, R;
- Wagner, J A
Publication type:
Article
Drug Trafficking: Recent Advances in Therapeutics and Disease.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 531, doi. 10.1038/clpt.2012.167
By:
- Sprowl, J A;
- Sparreboom, A
Publication type:
Article
Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 575, doi. 10.1038/clpt.2012.137
By:
- Savic, R M;
- Barrail-Tran, A;
- Duval, X;
- Nembot, G;
- Panhard, X;
- Descamps, D;
- Verstuyft, C;
- Vrijens, B;
- Taburet, A-M;
- Goujard, C;
- Mentré, F
Publication type:
Article
Contribution of the OATP1B Subfamily to Cancer Biology and Treatment.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 658, doi. 10.1038/clpt.2012.127
By:
- Sissung, T M;
- Reece, K M;
- Spencer, S;
- Figg, W D
Publication type:
Article
Prediction of Transporter-Mediated Drug-Drug Interactions Using Endogenous Compounds.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 546, doi. 10.1038/clpt.2012.145
By:
- Fromm, M F
Publication type:
Article
OATP1B1 Polymorphism as a Determinant of Erythromycin Disposition.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 642, doi. 10.1038/clpt.2012.106
By:
- Lancaster, C S;
- Bruun, G H;
- Peer, C J;
- Mikkelsen, T S;
- Corydon, T J;
- Gibson, A A;
- Hu, S;
- Orwick, S J;
- Mathijssen, R H J;
- Figg, W D;
- Baker, S D;
- Sparreboom, A
Publication type:
Article
Computational Modeling to Accelerate the Identification of Substrates and Inhibitors for Transporters That Affect Drug Disposition.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 661, doi. 10.1038/clpt.2012.164
By:
- Ekins, S;
- Polli, J E;
- Swaan, P W;
- Wright, S H
Publication type:
Article
Hepatocyte Hopping of OATP1B Substrates Contributes to Efficient Hepatic Detoxification.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 559, doi. 10.1038/clpt.2012.143
By:
- Iusuf, D;
- van de Steeg, E;
- Schinkel, A H
Publication type:
Article
N-Methylnicotinamide Is an Endogenous Probe for Evaluation of Drug-Drug Interactions Involving Multidrug and Toxin Extrusions (MATE1 and MATE2-K).
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 635, doi. 10.1038/clpt.2012.138
By:
- Ito, S;
- Kusuhara, H;
- Kumagai, Y;
- Moriyama, Y;
- Inoue, K;
- Kondo, T;
- Nakayama, H;
- Horita, S;
- Tanabe, K;
- Yuasa, H;
- Sugiyama, Y
Publication type:
Article
A Perspective on Efflux Transport Proteins in the Liver.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 599, doi. 10.1038/clpt.2012.79
By:
- Köck, K;
- Brouwer, K L R
Publication type:
Article
Pomegranate Juice and Pomegranate Extract Do Not Impair Oral Clearance of Flurbiprofen in Human Volunteers: Divergence From In Vitro Results.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 651, doi. 10.1038/clpt.2012.170
By:
- Hanley, M J;
- Masse, G;
- Harmatz, J S;
- Court, M H;
- Greenblatt, D J
Publication type:
Article
In This Issue.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 529, doi. 10.1038/clpt.2012.174
Publication type:
Article
Highlights from the International Transporter Consortium Second Workshop.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 553, doi. 10.1038/clpt.2012.126
By:
- Zamek-Gliszczynski, M J;
- Hoffmaster, K A;
- Tweedie, D J;
- Giacomini, K M;
- Hillgren, K M
Publication type:
Article
Highlights.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 538, doi. 10.1038/clpt.2012.173
Publication type:
Article
A Step Closer to Personalized Chemotherapy: Consideration of the Influence of Genetic Variation in Hepatic Uptake Transporters on the Metabolism of CYP3A Substrates.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 551, doi. 10.1038/clpt.2012.165
By:
- Benet, L Z
Publication type:
Article
Corrigendum: Models for Disease Progression: New Approaches and Uses.
Published in:
2012
Publication type:
Erratum
The TGF-β Pathway as an Emerging Target for Chagas Disease Therapy.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 613, doi. 10.1038/clpt.2012.102
By:
- Araújo-Jorge, T C;
- Waghabi, M C;
- Bailly, S;
- Feige, J-J
Publication type:
Article
ASCPT News.
Published in:
Clinical Pharmacology & Therapeutics, 2012, v. 92, n. 5, p. 540, doi. 10.1038/clpt.2012.169
Publication type:
Article